Literature DB >> 2384803

Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol.

M Schwaiger1, H Guibourg, K Rosenspire, T McClanahan, K Gallagher, G Hutchins, D M Wieland.   

Abstract

With the introduction of radiolabeled catecholamine analogues, the noninvasive evaluation of the cardiac sympathetic nervous system has become possible. This study evaluated the effect of regional ischemia on myocardial retention of the new norepinephrine analogue 6-[18F] fluorometaraminol (FMR) in the open chest dog model. Six dogs were injected intravenously with FMR following 30-min occlusion of the left anterior descending artery. Six sham animals served as control group. Regional myocardial blood flow as determined by microspheres decreased 87% during ischemia (p less than 0.01), but was not significantly different from control myocardium following reperfusion. Regional myocardial 18F activity as determined postmortem was significantly reduced in reperfused myocardium (-34%), which paralleled an 18% reduction of tissue norepinephrine concentration. Thus, short time periods of coronary occlusion affect neuronal function indicating the sensitivity of the sympathetic nerve terminals to ischemia. FMR provides a new tracer approach for the characterization of neuronal integrity in postischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384803

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

Review 2.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

3.  Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.

Authors:  Cecilia Marini; Assuero Giorgetti; Alessia Gimelli; Annette Kusch; Nadia Sereni; Antonio L'abbate; Paolo Marzullo; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

Review 4.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 5.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

6.  Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography.

Authors:  C Guertner; H Klepzig; F D Maul; A Hartmann; S Lelbach; A Hellmann; G Hoer
Journal:  Eur J Nucl Med       Date:  1993-09

Review 7.  Assessment of cardiac sympathetic neuronal function using PET imaging.

Authors:  Frank M Bengel; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

8.  Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.

Authors:  M Estorch; R Serra-Grima; I Carrió; A Flotats; A Lizárraga; L L Bernà; T Prats; R Segura
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

9.  Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model.

Authors:  C R Berry; P K Garg; T R DeGrado; P Hellyer; W Weber; S Garg; B Hansen; M R Zalutsky; R E Coleman
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

Review 10.  Imaging cardiac neuronal function and dysfunction.

Authors:  Takahiro Higuchi; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.